![Juan M. E. Harrison](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Juan M. E. Harrison
Directeur/Membre du Conseil chez
Bridge Medicines LLC
Profil
Juan M.
E.
Harrison is currently a Director at Bridge Medicines LLC.
Previously, he held positions as President, Chief Executive Officer & Director at Imidomics, Inc., Principal at ALZA Corp., Connetics Corp., and XenoPort, Inc., Vice President at Takeda Ventures, Inc., and Principal at PowderJect Vaccines, Inc. He was also a Partner at Propharma Partners International, Inc. in 2007.
Harrison received his undergraduate degree from Santa Clara University.
Postes actifs de Juan M. E. Harrison
| Sociétés | Poste | Début |
|---|---|---|
Bridge Medicines LLC
 Bridge Medicines LLC Pharmaceuticals: MajorHealth Technology Operates as a bio-technology firm that develops therapeutics for oncology, neuropsychiatry and rare diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Juan M. E. Harrison
| Sociétés | Poste | Fin |
|---|---|---|
Propharma Partners International, Inc. | Corporate Officer/Principal | 31/12/2007 |
Imidomics, Inc.
 Imidomics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of medicines for immune-mediated inflammatory diseases | Directeur Général | - |
PowderJect Vaccines, Inc. | Corporate Officer/Principal | - |
| ALZA CORPORATION | Corporate Officer/Principal | - |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Corporate Officer/Principal | - |
Formation de Juan M. E. Harrison
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Ventures, Inc.
 Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures invests in companies located across the globe. The firm focuses on high-caliber, therapeutic, platform-based companies. It provides financing for early stage capital requirements. | Finance |
PowderJect Vaccines, Inc. | |
Propharma Partners International, Inc. | |
Bridge Medicines LLC
Bridge Medicines LLC Pharmaceuticals: MajorHealth Technology Operates as a bio-technology firm that develops therapeutics for oncology, neuropsychiatry and rare diseases | Health Technology |
Imidomics, Inc.
Imidomics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of medicines for immune-mediated inflammatory diseases | Commercial Services |
